TG Therapeutics | TGTX - Trade Creditors


TG Therapeutics reported $148.84M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 2.86B 16.65B Jun/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 403.9M 45.4M Jun/2026
Corcept Therapeutics USD 14.91M 18.4M Jun/2026
Curis USD 6.74M 1.13M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
J&J USD 9.22B 1.24B Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novavax USD 22.94M 6.84M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Verastem USD 9.6M 2.85M Mar/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026